Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148,275,293
-
Total 13F shares
-
17,322,134
-
Share change
-
+464,636
-
Total reported value
-
$339,441,000
-
Put/Call ratio
-
0%
-
Price per share
-
$19.59
-
Number of holders
-
47
-
Value change
-
+$9,163,211
-
Number of buys
-
16
-
Number of sells
-
23
Institutional Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q3 2021
As of 30 Sep 2021 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) had 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,322,134 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, EVENTIDE ASSET MANAGEMENT, LLC, FRANKLIN RESOURCES INC, BlackRock Inc., FMR LLC, VANGUARD GROUP INC, Candriam Luxembourg S.C.A., and CITADEL ADVISORS LLC.
This table shows 47 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.